NICE/PHE pneumonia: antimicrobial prescribing guideline

Streptococcus Pneumoniae_AS

This summary covers an antimicrobial prescribing strategy for patients with community-acquired pneumonia.

Community-acquired pneumonia is a lower respiratory tract infection that is most commonly caused by bacterial infection. The main bacterial pathogen is Streptococcus pneumoniae, however Mycoplasma pneumoniae occurs in outbreaks approximately every 4 years in the UK.

Using antibiotics when they are not needed means they may not work as well in the future. This is a serious health risk so NICE has written advice about when to offer antibiotics for some common conditions.

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with a confirmed diagnosis of community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

This Guidelines summary covers:

  • Managing community-acquired pneumonia
    • Treatment for adults, young people and children
    • Advice
    • Reassessment
    • Referral and seeking specialist advice
  • Choice of antibiotic for:
    • adults aged 18 years and over
    • children and young people under 18 years

Register or subscribe to view this content

Please sign in to continue reading this content, or …

Register

Guidelines for Nurses is free for UK-based doctors, nurses, and pharmacists.

Sign-up now—it takes just a few minutes and you’ll get unlimited access to all of our content, including summaries, expert articles, tools and resources, and CPD modules.

Read for £5

Pay £5.00 to continue reading this content.

This will entitle you to unlimited access to our summaries, expert articles, and CPD modules for 30 days.